Cargando…

The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review

OBJECTIVES: Evidence-informed priority setting, in particular cost-effectiveness analysis (CEA), can help target resources better to achieve universal health coverage. Central to the application of CEA is the use of a cost-effectiveness threshold. We add to the literature by looking at what threshol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazibwe, Joseph, Gheorghe, Adrian, Wilson, David, Ruiz, Francis, Chalkidou, Kalipso, Chi, Y-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885424/
https://www.ncbi.nlm.nih.gov/pubmed/35227450
http://dx.doi.org/10.1016/j.jval.2021.08.014
_version_ 1784660417069449216
author Kazibwe, Joseph
Gheorghe, Adrian
Wilson, David
Ruiz, Francis
Chalkidou, Kalipso
Chi, Y-Ling
author_facet Kazibwe, Joseph
Gheorghe, Adrian
Wilson, David
Ruiz, Francis
Chalkidou, Kalipso
Chi, Y-Ling
author_sort Kazibwe, Joseph
collection PubMed
description OBJECTIVES: Evidence-informed priority setting, in particular cost-effectiveness analysis (CEA), can help target resources better to achieve universal health coverage. Central to the application of CEA is the use of a cost-effectiveness threshold. We add to the literature by looking at what thresholds have been used in published CEA and the proportion of interventions found to be cost-effective, by type of threshold. METHODS: We identified CEA studies in low- and middle-income countries from the Global Health Cost-Effectiveness Analysis Registry that were published between January 1, 2015, and January 6, 2020. We extracted data on the country of focus, type of interventions under consideration, funder, threshold used, and recommendations. RESULTS: A total of 230 studies with a total 713 interventions were included in this review; 1 to 3× gross domestic product (GDP) per capita was the most common type of threshold used in judging cost-effectiveness (84.3%). Approximately a third of studies (34.2%) using 1 to 3× GDP per capita applied a threshold at 3× GDP per capita. We have found that no study used locally developed thresholds. We found that 79.3% of interventions received a recommendation as “cost-effective” and that 85.9% of studies had at least 1 intervention that was considered cost-effective. The use of 1 to 3× GDP per capita led to a higher proportion of study interventions being judged as cost-effective compared with other types of thresholds. CONCLUSIONS: Despite the wide concerns about the use of 1 to 3× GDP per capita, this threshold is still widely used in the literature. Using this threshold leads to more interventions being recommended as “cost-effective.” This study further explore alternatives to the 1 to 3× GDP as a decision rule.
format Online
Article
Text
id pubmed-8885424
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88854242022-03-02 The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review Kazibwe, Joseph Gheorghe, Adrian Wilson, David Ruiz, Francis Chalkidou, Kalipso Chi, Y-Ling Value Health Brief Report OBJECTIVES: Evidence-informed priority setting, in particular cost-effectiveness analysis (CEA), can help target resources better to achieve universal health coverage. Central to the application of CEA is the use of a cost-effectiveness threshold. We add to the literature by looking at what thresholds have been used in published CEA and the proportion of interventions found to be cost-effective, by type of threshold. METHODS: We identified CEA studies in low- and middle-income countries from the Global Health Cost-Effectiveness Analysis Registry that were published between January 1, 2015, and January 6, 2020. We extracted data on the country of focus, type of interventions under consideration, funder, threshold used, and recommendations. RESULTS: A total of 230 studies with a total 713 interventions were included in this review; 1 to 3× gross domestic product (GDP) per capita was the most common type of threshold used in judging cost-effectiveness (84.3%). Approximately a third of studies (34.2%) using 1 to 3× GDP per capita applied a threshold at 3× GDP per capita. We have found that no study used locally developed thresholds. We found that 79.3% of interventions received a recommendation as “cost-effective” and that 85.9% of studies had at least 1 intervention that was considered cost-effective. The use of 1 to 3× GDP per capita led to a higher proportion of study interventions being judged as cost-effective compared with other types of thresholds. CONCLUSIONS: Despite the wide concerns about the use of 1 to 3× GDP per capita, this threshold is still widely used in the literature. Using this threshold leads to more interventions being recommended as “cost-effective.” This study further explore alternatives to the 1 to 3× GDP as a decision rule. Elsevier 2022-03 /pmc/articles/PMC8885424/ /pubmed/35227450 http://dx.doi.org/10.1016/j.jval.2021.08.014 Text en © 2021 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Kazibwe, Joseph
Gheorghe, Adrian
Wilson, David
Ruiz, Francis
Chalkidou, Kalipso
Chi, Y-Ling
The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
title The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
title_full The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
title_fullStr The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
title_full_unstemmed The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
title_short The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review
title_sort use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885424/
https://www.ncbi.nlm.nih.gov/pubmed/35227450
http://dx.doi.org/10.1016/j.jval.2021.08.014
work_keys_str_mv AT kazibwejoseph theuseofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT gheorgheadrian theuseofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT wilsondavid theuseofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT ruizfrancis theuseofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT chalkidoukalipso theuseofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT chiyling theuseofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT kazibwejoseph useofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT gheorgheadrian useofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT wilsondavid useofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT ruizfrancis useofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT chalkidoukalipso useofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview
AT chiyling useofcosteffectivenessthresholdsforevaluatinghealthinterventionsinlowandmiddleincomecountriesfrom2015to2020areview